Sonoma Orthopedic Products added $12 million to its coffers, thanks to private equity shop First Analysis, saying it plans to use the proceeds to get its “flexible-to rigid” ankle implant on the U.S. market.
Sonoma, which develops implants to treat the extremities, said it plans to use the First Analysis infusion to win 510(k) clearance from the FDA for the ankle device, and then carry it though to launch and achieving commercial scale.
Help employers find you! Check out all the jobs and post your resume.
